Multiple Sclerosis: Mechanisms and Immunotherapy

Neuron
Clare Baecher-AllanHoward L Weiner

Abstract

Multiple sclerosis (MS) is an autoimmune disease triggered by environmental factors that act on a genetically susceptible host. It features three clinical stages: a pre-clinical stage detectable only by MRI; a relapsing-remitting (RRMS) stage characterized by episodes of neurologic dysfunction followed by resolution; and a progressive stage, which usually evolves from the relapsing stage. Advances in our understanding of the immune mechanisms that contribute to MS have led to more than ten FDA-approved immunotherapeutic drugs that target effector T cells, regulatory cells, B cells, and cell trafficking into the nervous system. However, most drugs for relapsing MS are not effective in treating progressive disease. Progressive MS features a compartmentalized immune response in the central nervous system, involving microglia cells and astrocytes, as well as immune-independent processes that drive axonal dysfunction. Major challenges for MS research involve understanding the mechanisms of disease progression, developing treatment for progressive MS, and determining the degree to which progressive disease can be prevented by early treatment. Key priorities for MS research include developing biomarkers, personalized medicine and adva...Continue Reading

Citations

Jul 4, 2018·SLAS Discovery·Tessa SwantonDavid Brough
Aug 24, 2018·Multiple Sclerosis : Clinical and Laboratory Research·Francisco J Quintana
Dec 21, 2018·Expert Review of Neurotherapeutics·Kévin BigautNicolas Collongues
Jan 10, 2019·Annual Review of Pharmacology and Toxicology·Jerold ChunVictoria A Blaho
Feb 6, 2019·The Journal of Infectious Diseases·Kurt-Wolfram SühsFrank Pessler
May 31, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Federica PianconeMario Clerici
Dec 11, 2019·Cancer Medicine·Tareq M AnssarCorinna Seliger
Jan 5, 2020·Expert Opinion on Therapeutic Targets·Alessandra MusellaGeorgia Mandolesi
Jan 30, 2020·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Rohit BakshiUNKNOWN SUMMIT consortium
Nov 13, 2019·Multiple Sclerosis : Clinical and Laboratory Research·Jonathan ZurawskiRohit Bakshi
Feb 15, 2020·Journal of Neuroscience Research·Victoria LioudynoMaria Lioudyno
Feb 13, 2020·Journal of Clinical Medicine·Davide MarangonMarta Fumagalli
Feb 26, 2020·Cells·Martina KunklLoretta Tuosto
Feb 14, 2020·Nature·Michael A WheelerFrancisco J Quintana
Feb 23, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J ZurawskiM Houtchens
Jun 4, 2020·Brain Sciences·Olga Kammona, Costas Kiparissides
May 14, 2020·Journal of Neurochemistry·Manal AlaameryFrancisco J Quintana
Jul 10, 2020·Multiple Sclerosis : Clinical and Laboratory Research·Kévin BigautOlivier Outteryck
Jul 15, 2020·Expert Opinion on Drug Discovery·Giulia RussoFrancesco Pappalardo
Aug 20, 2019·Nature Reviews. Neurology·Paul M Matthews
Aug 18, 2020·Journal of Neuroscience Research·Dunja D BijelićLjiljana M Nikolić
Sep 19, 2019·Scientific Reports·Anne Skøttrup MørkholtJohn Dirk Vestergaard Nieland
Aug 29, 2020·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Malte BorggreweJon D Laman
Jun 14, 2018·Nature Reviews. Neurology·Stefan Bittner, Frauke Zipp
May 26, 2018·Expert Review of Neurotherapeutics·Nicolas CollonguesTobias Derfuss
Nov 12, 2018·Auto- Immunity Highlights·Georgios K VasileiadisGeorgios M Hadjigeorgiou
Dec 12, 2018·Frontiers in Molecular Neuroscience·Iñaki Osorio-QuerejetaDavid Otaegui
Feb 23, 2019·Frontiers in Immunology·Laurine LegrouxNathalie Arbour
May 28, 2019·Frontiers in Immunology·Iris LavonAdi Vaknin-Dembinsky
Oct 23, 2019·Neural Regeneration Research·Wensheng Lin, Sarrabeth Stone
Feb 13, 2020·Frontiers in Oncology·Paul DentJohn F Hancock
Jun 12, 2020·Der Nervenarzt·Jonas GrafHans-Peter Hartung
Sep 28, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yipeng ZhaoXiaoHua He
Sep 20, 2020·Science Immunology·Jenna L PappalardoDavid A Hafler
Nov 10, 2018·Nature Reviews. Disease Primers·Massimo FilippiMaria A Rocca
Feb 23, 2019·Biomedicines·Jorge CorrealeMaría Célica Ysrraelit
Aug 5, 2019·Cellular and Molecular Life Sciences : CMLS·Laura FantuzziLucia Lopalco
May 28, 2019·Metabolic Brain Disease·Behnaz Salek EsfahaniMaryam Rezazadeh
Apr 25, 2019·EMBO Molecular Medicine·Sofie VoetGeert van Loo
Jan 30, 2020·CNS Drugs·Finn SellebjergPer Soelberg Sorensen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Related Papers

Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
Hanne F HarboAnne Spurkland
Current Opinion in Immunology
Veit Rothhammer, Francisco J Quintana
© 2022 Meta ULC. All rights reserved